Special Issue

Lung Transplant

Submission Deadline: February 28, 2017 (Closed)

Guest Editor

Kamyar Afshar, DO

Clinical Associate Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, San Diego, CA, USA

Website | E-Mail

Research Interests: evaluation and management of lung transplantation; alpha 1 antitrypsin deficiency/copd and advanced stages management; sarcoidosis; lymphangioleiomyomatosis and interstitial lung disease management; phenotypic variance in cystic fibrosis

Manuscript Submission Information

Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (transplantation@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.

Welcome your submission!

Publication

Open Access Original Research Low Mortality Associated with COVID-19 Infection in Lung Transplant Recipients at a Single Center by Rahul F. Gomez  , Aarya Kafi  , Gordon Yung  , Saima Aslam  , Christine M. Lin  , Travis Pollema  , Eugene Golts  and Kamyar Afshar Received: 15 October 2023;  Published: 28 April 2024;  doi: 10.21926/obm.transplant.2402213 Abstract Lung Transplant Recipients (LTR) are particularly vulnerable to severe infection, hospitalization, and death due to community acquired respiratory viruses. As a result, the global SARS-Cov-2 pandemic poses a higher risk to this population. We aim to study the lung function, severity of infection and mortality among LTR at a single [...]

Open Access Case Report Alpha-1 Antitrypsin Deficiency and Lung Transplantation: A Clinical Case by Victoria Lorenzetti  , Elena Bargagli  , Antonella Fossi  , David Bennett  , Paolo Cameli  and Paola Rottoli Received: 30 August 2018;  Published: 18 December 2018;  doi: 10.21926/obm.transplant.1804033 Abstract BACKGROUND: α1-antitrypsin deficiency is the most common hereditary disorder in adults and is associated to an increased risk of developing lung emphysema. METHODS: With this case report, we describe the case of a 54 years old patient, who underwent bilateral lung transplantation due to alpha-1 antitrypsin deficiency emphysema. RESULTS: [...]

Open Access Case Report Case of Lung Transplantation in a Recipient with Emphysema: Importance of Determining Alpha 1-Antitrypsin Deficiency Status for Lung Transplantation by Christine M. Bojanowski  , Ian Britton  and Kamyar Afshar Received: 18 April 2018;  Published: 16 July 2018;  doi: 10.21926/obm.transplant.1803015 Abstract Here we present a case of a lung transplant recipient with alpha 1-antitrypsin deficiency as well as conducted a retrospective review of the United Network for Organ Sharing (UNOS) database from 1990 – 2016 specifically grouping patients with alpha-1 antitrypsin deficiency (A1ATD) and chronic obstructive pulmonary disease (COPD).

Open Access Review Malignancy in the Lung Transplant Population by Mark M Fuster  and Sheri Tran Received: 16 July 2017;  Published: 12 September 2017;  doi: 10.21926/obm.transplant.1703004 Abstract The risk for developing a variety of malignancies is significantly elevated in the setting of lung transplantation. Malignancy remains among the three major causes of death in post-transplant recipients, and the relatively high risk of cancer development as well as metastatic aggression pose special threats to this population due to the need [...]

Open Access Review IVIG Replacement for Hypogammaglobulinemia in Lung Transplant Patients by In Lam  , Irina Gutman  , Ashley Feist  and Mark Mariski Received: 10 March 2017;  Published: 22 June 2017;  doi: 10.21926/obm.transplant.1701003 Abstract After lung transplant, infection is a leading contributor to morbidity and mortality, and hypogammaglobulinemia (HGG) may be an important risk factor for many of these infections.  Some reports suggest that HGG not only increases the risk of various infections, but also worsens survival.  The incidence of HGG has been shown to increase [...]